One of the four defendant Chinese companies has filed a proposed settlement in U.S. District Court in Brooklyn to resolve In re: Vitamin C Antitrust Litigation. The lawsuit, brought by commercial buyers of vitamin C, alleges that the companies formed a cartel to raise prices by limiting exports. The settlement calls for Aland Nutraceutical Co. (formerly Jiangsu Jiangshuan) to pay $9.5 million to direct purchasers, and $1 million to indirect purchasers.
Featured News
FTC Scrutinizes Proposed $3.5 Billion Veterinary Products Merger
Aug 4, 2026 by
CPI
Apple Seeks Court Order in AI Trade Secrets Dispute With OpenAI
Aug 4, 2026 by
CPI
Australian Competition Watchdog Accepts EnergyAustralia Undertaking Over Retail Rule Breach
Aug 4, 2026 by
CPI
South Korea Weighs Sweeping Antitrust Overhaul
Aug 4, 2026 by
CPI
Reed Smith Strengthens European Antitrust Team With London Addition
Aug 4, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes